By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Syndax Pharmaceuticals Inc. 

400 Totten Pond Road
Suite 110
Waltham  Massachusetts  02451  U.S.A.
Phone: 781-419-1400 Fax: 781-419-1420


Start Up

Company News
Syndax Reports Second Quarter 2016 Financial Results And Provides Business Update 8/9/2016 10:57:38 AM
Syndax Appoints Leading Experts To Scientific Advisory Board (SAB) 7/27/2016 8:44:25 AM
Syndax To Announce Second Quarter 2016 Financial Results And Host Conference Call And Webcast On August 9, 2016 7/21/2016 8:16:17 AM
Syndax To Present At The Cantor Fitzgerald 2nd Annual Healthcare Conference 7/7/2016 10:20:29 AM
Syndax Expands Pipeline With Exclusive Worldwide License Agreement For UCB Group (UCBJF.PK)’s Colony Stimulating Factor 1 Receptor (CSF-1R) Antibody Program 7/6/2016 8:05:34 AM
Allan L. Shaw Joins Syndax As Chief Financial Officer 1/20/2016 6:24:13 AM
Six Biotechs Start Out 2016 By Filing IPOs 1/5/2016 8:13:44 AM
Merck KGaA (MKGAF.PK), Darmstadt, Germany, Pfizer (PFE) And Syndax Announce Collaboration To Evaluate Combination Of Avelumab And Entinostat In Ovarian Cancer 1/4/2016 7:46:12 AM
Syndax Announces Multiple Data Presentations On Entinostat At Upcoming San Antonio Breast Cancer Symposium 12/3/2015 7:35:35 AM
Syndax And Merck & Co. (MRK) Announce First Patients Dosed In Phase 1b/2 Clinical Trial Of Entinostat And KEYTRUDA 9/28/2015 7:58:57 AM